Use of Different Electrophysical Agents in Cervical Region Flexibility Training of Healthy Individuals

December 29, 2023 updated by: ATİYE KAŞ ÖZDEMİR, Pamukkale University
60 healthy participants with right / left upper trapezoidal shortness based on volunteering will be included in the study. Participants were randomly divided into 4 groups; Traction and stretching exercises to group 1 (n = 15), laser therapy and stretching exercise to group 2 (n = 15), hot pack and stretching exercises to group 3 (n = 15), and group 4 (control group) only stretching exercises will be applied.

Study Overview

Detailed Description

Healthy individuals without any cervical region pathology will be included in the study. Exclusion criterias are pregnancy or cancer, hypertension that cannot be controlled, having neurological symptoms, previous spinal surgery.

Demographic information of the participants will be recorded; cervical joint range of motion (CROM device), muscle shortness (acromion-earlobe and occiput-wall distance measurement), deep cervical flexor muscle strength (Stabilizer Pressure Biofeedback), cervical performance level (Cervical Performance Tests), muscle spasm (Palpable Muscle Spasm Scoring) will be evaluated. Cervical joint range of motion and muscle shortening will be repeated before and after each session, but other parameters will only be repeated at the beginning and the end.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Denizli, Turkey
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

-Healthy individuals without any cervical region pathology

Exclusion Criteria:

  • Pregnancy and cancer
  • Uncontrolled hypertension
  • Presence of neurological symptoms
  • Spinal surgery history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Traction and stretching
This grup received stretching exercises after traction therapy for 18 sessions, 3 times per week.
Intermittent traction will be applied to the cervical region in a supine position with the neck at 25-30 ° flexion. The target weight is determined as 10% of the patient's weight. Traction pulling force applied to the target weight will be achieved gradually increasing from low. Traction therapy will be applied intermittent traction for 15 minutes in each session as 60 seconds retention and 60 seconds rest. The therapy will be held for 18 sessions, 3 days / week.
Stretching exercises will be repeated 3 times a day in total, 2 times a day self-stretching at home and 1 time under the supervision of a physiotherapist. Exercises for upper trapezius muscle, sternokleudomasteudeus (SCM) muscle and the scalene muscle to be applied in a 3 repeat by waiting 30 seconds, stretching under tension.The therapy will be held for 18 sessions, 3 days / week.
Experimental: Laser therapy and stretching
This grup received stretching exercises after laser therapy for 18 sessions, 3 times per week.
Stretching exercises will be repeated 3 times a day in total, 2 times a day self-stretching at home and 1 time under the supervision of a physiotherapist. Exercises for upper trapezius muscle, sternokleudomasteudeus (SCM) muscle and the scalene muscle to be applied in a 3 repeat by waiting 30 seconds, stretching under tension.The therapy will be held for 18 sessions, 3 days / week.
Laser therapy will be applied to the participants with a GaAs laser with 904 nm wavelength, 6 points transforaminally, 120 seconds to each point, at 2 J / cm² density, total dose of 12 J laser therapy by keeping the probe in constant contact with the skin.
Experimental: Hot pack and stretching
This grup received stretching exercises after hotpack therapy for 18 sessions, 3 times per week.
Stretching exercises will be repeated 3 times a day in total, 2 times a day self-stretching at home and 1 time under the supervision of a physiotherapist. Exercises for upper trapezius muscle, sternokleudomasteudeus (SCM) muscle and the scalene muscle to be applied in a 3 repeat by waiting 30 seconds, stretching under tension.The therapy will be held for 18 sessions, 3 days / week.
The hot pack, which is the superficial heat agent, will be held in the neck area of the participants for 20 minutes in each session.The therapy will be held for 18 sessions, 3 days / week.
Experimental: Stretching only
This grup received only stretching exercises for 18 sessions, 3 times per week.
Stretching exercises will be repeated 3 times a day in total, 2 times a day self-stretching at home and 1 time under the supervision of a physiotherapist. Exercises for upper trapezius muscle, sternokleudomasteudeus (SCM) muscle and the scalene muscle to be applied in a 3 repeat by waiting 30 seconds, stretching under tension.The therapy will be held for 18 sessions, 3 days / week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervical range of motion (ROM)
Time Frame: Baseline to 6 weeks after
ROM is measured by CROM device during flexion, extension, right/left lateral flexion and right/left rotation activity.
Baseline to 6 weeks after
Cervical flexibility
Time Frame: Baseline to 6 weeks after
Cervical flexibility is measured using the standard tape measure, the distance between the occiput and the wall in the standing position of the participants, and the distance between the earlobe and the acromion.
Baseline to 6 weeks after

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervikal Muscle spasm
Time Frame: Baseline to 6 weeks after
The degree of muscular spasm in the upper trapezoidal muscle, sternocleudomasteudeus (SCM) muscle, and scalen muscles is evaluated by palpation over 4 points.
Baseline to 6 weeks after

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervical Performance Level
Time Frame: Baseline to 6 weeks after
In cervical flexion, extension, right and left lateral flexion directions, cervical performance tests are evaluated by recording the holding time in the desired position with a stopwatch.
Baseline to 6 weeks after
Muscle Strength of Deep Cervical Flexor Muscles
Time Frame: Baseline to 6 weeks after
Strength measurement of deep cervical flexor muscles is evaluated with the Stabilizer Pressure Biofeedback device (Chattanooga Medical Suplly Inc, Chattanooga, TN).
Baseline to 6 weeks after

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Şule ŞİMŞEK, PhD, Pamukkale University
  • Study Chair: Ummuhan BAŞ ASLAN, Prof. Dr., Pamukkale University
  • Study Chair: Merve BERGİN KORKMAZ, Dr., Denizli Devlet Hastanesi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2019

Primary Completion (Actual)

August 18, 2022

Study Completion (Actual)

August 19, 2022

Study Registration Dates

First Submitted

March 27, 2020

First Submitted That Met QC Criteria

March 31, 2020

First Posted (Actual)

April 1, 2020

Study Record Updates

Last Update Posted (Actual)

January 2, 2024

Last Update Submitted That Met QC Criteria

December 29, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018KRM019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

there is no web site to share data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Therapy

Clinical Trials on Traction

3
Subscribe